Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study

Frontiers In Medicine

by Junjie Zhang, Ci Ren, Zihan Qin, Ling Zhu, Zhoufeng Jin, Yuanyuan Yan, Xinghe Pan, Lan Luan
May 6, 2026

Jama Dermatology

Three-Year Outcomes Reported by Patients Using Bimekizumab for Plaque Psoriasis: Findings from the BE RADIANT Randomized Trial

by Matthias Augustin, Steven R. Feldman, Richard B. Warren, April Armstrong, Ronald Vender, Anna López-Ferrer, William H. Dawe, Jérémy Lambert, Balint Szilagyi, Bengt Hoepken, Rhys Warham, Alice B. Gottlieb
April 1, 2026

Conexiant

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

by Kerri Miller
April 17, 2026
6 min

Dermatology And Therapy (Springer)

Efficacy and Safety of Deucravacitinib for Psoriasis: A Multicenter Real-World Analysis Focusing on Scalp Outcomes—IL PSO (Italian Landscape Psoriasis)

Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study

Original Source(s)

Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study

Related Content

Three-Year Outcomes Reported by Patients Using Bimekizumab for Plaque Psoriasis: Findings from the BE RADIANT Randomized Trial

AI Scribes Lag Clinicians on Note Quality

Efficacy and Safety of Deucravacitinib for Psoriasis: A Multicenter Real-World Analysis Focusing on Scalp Outcomes—IL PSO (Italian Landscape Psoriasis)